Handa Pharmaceuticals Inc(TW:6620)
NT$136.50+11.00 (+8.76%)
TW:6620
Handa Pharmaceuticals Inc Revenue
NT$136.50
At close:+11.00 (+8.76%)
Handa Pharmaceuticals Inc (6620) Revenue
Handa Pharmaceuticals Inc Revenue
Handa Pharmaceuticals Inc had a revenue of 211.95M in the quarter ending Jun 30, 2026, with 1.11%. This bring the company's revenue in the last twelve months to 1.21B, Decreased 17.56%. In the fiscal year ending Dec 31, 2025, Handa Pharmaceuticals Inc had annual revenue of 1.73B with 108.17% growth.
- Revenue (ttm)
- 1.21B
- Revenue Growth
- ―
- P/S Ratio
- 12.05
- Revenue/Employee
- TWD 115,283,467
- Employees
- 15
- Market Cap
- TWD 20.83B
Revenue Chart
Handa Pharmaceuticals Inc Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.73B | 898.58M | 108.17% |
| Dec 31, 2024 | 830.67M | -275.65M | -24.92% |
| Dec 31, 2023 | 1.11B | 908.64M | 459.66% |
| Dec 31, 2022 | 197.68M | 168.44M | 576.16% |
| Dec 31, 2021 | 29.23M | 376.00K | 1.30% |
| Dec 31, 2020 | 28.86M | -55.21M | -65.67% |
| Dec 31, 2019 | 84.07M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.